Champignon Brands Inc. SHRM Archives

ThursdayApr 23, 2020 10:19 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Commences Trading on the OTCQB Venture Market

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares have graduated from the OTC Pink Open Market to the OTCQB Venture Market (the “OTCQB”), a U.S. trading platform operated by the OTC Markets Group. Effective immediately, Champignon Brands will commence trading on the OTCQB under the ticker symbol “SHRMF.” Champignon’s common shares will continue to trade under the ticker symbol “SHRM” on the Canadian Securities Exchange as…

WednesdayApr 22, 2020 9:25 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Research Partner Secures Steady Psilocybin Supply for Clinical Studies

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company that is advancing its clinical pipeline through its ongoing TBI/PTSD-focused preclinical studies at the University of Miami’s Miller School of Medicine, today announced that its research partner and lead investigator, Dr. Michael Hoffer, has obtained a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies. Under a collaborative research agreement with the University of Miami's Miller School of Medicine, Champignon’s wholly owned subsidiary, Tassili Life Sciences Corp., is conducting preclinical studies and eventual human clinical trials, with…

ThursdayApr 16, 2020 9:20 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Names New Member to Special Advisory Committee

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, this morning announced the appointment of the former President of Red Bull Canada, Mr. Jim Bailey, to its Special Advisory Committee. Bailey will support in the marketing, distribution and commercialization of Champignon’s Novoformulations-branded novel delivery systems targeting the pharmaceutical, nutraceutical and psychedelic medicine industries. “I am very excited to be part of a company that is leading the way in finding alternative solutions to…

MondayApr 13, 2020 10:26 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Enters Definitive Agreement to Acquire AltMed Capital Corp.

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to accelerate its advancements within the psychedelic medicine arena. On Thursday, Champignon Brands announced its plans to acquire a leading Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer (the “Transaction”) and has entered into a definitive agreement (the “Agreement”) to acquire 100% of AltMed Capital Corp. (“AltMed”). “Founded and operated by Dr. McIntyre, the CRTCE has the human capital…

ThursdayApr 09, 2020 11:33 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Aims to Support Mental Health, Develop Improved Treatments Using Psilocybin Mushrooms

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human-optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, offers a timely line of organic, non-GMO and vegan-certified products. In 2019, Johns Hopkins launched a center for psychedelic research backed by private funders (http://ibn.fm/mtUhg). A recent article discussing the company reads, “The focus of John Hopkin’s studies will be on the affect psychedelics have on behavior, brain function, learning and memory, and the brain’s biology and mood. New therapies and the effectiveness of psilocybin…

WednesdayApr 08, 2020 11:50 am

Champignon Brands Inc. (CSE: SHRM) Commences Trading on CSE; Evolving Product Portfolio to Support Mental Health, Cognitive Performance

SHRM completed successful IPO, raising $2.8 million; lists its stocks in the U.S. and Germany Unlike rapidly declining general market, nascent industry reports rapid growth, yet few players occupy the space SHRM well positioned to capitalize on the burgeoning market, placed ahead of scarce competition Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) is a Canadian research-driven company specializing in the formulation of medicinal-mushroom health products, and novel delivery platforms for the pharmaceutical and nutraceutical industries. SHRM is poised for rapid growth as the emerging psychedelics sector has been on the rise amid volatility that is taking place in…

TuesdayMar 31, 2020 10:13 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands Special Advisory Committee with Appointment of University of Toronto Clinical Advisor, Pharmacognosist

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced continued augmentation of its Special Advisory Committee with the addition of key individuals experienced in highly regulated industries primed for rapid growth. To this accord, the Company announced the appointment of Jay Kheita, ACPR, to its Special Advisory Committee, where he will help lead the integration of Champignon’s novel and natural treatment protocols into its existing consumer packaged goods (“CPGs”) portfolio. Khetia…

MondayMar 30, 2020 11:03 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Enters Definitive Agreement to Acquire Tassili Life Sciences Corp.

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of medicinal mushrooms health products and novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced its entry into a definitive agreement to acquire Tassili Life Sciences Corp. Per the update, the move will expand the Company’s preclinical trial pipeline, as well as its aggregation of broad intellectual property (IP) related to the development of novel psychedelics therapeutics and their delivery systems, targeting multiple pathological psychological diseases. Tassili has partnered with a multidisciplinary team of scientists and physicians at the University of…

WednesdayMar 25, 2020 11:19 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Appoints Ernst & Young 2018 Entrepreneur of the Year in Health Care to Special Advisory Committee

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee. According to the update, Dr. Gabriele, PhD, specializes in the areas of molecular pharmacology, transdermal delivery and formulation chemistry with pharmaceutical, natural molecules and will champion the company’s development and commercialization of rapid onset treatments capable of improving…

MondayMar 23, 2020 12:55 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) CEO Shares Strategic Goals in Exclusive Audio Interview

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering…

Site Search

Company Search

Tag: Champignon Brands Inc. SHRM